Ubs Group Ag Sana Biotechnology, Inc. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 1,145,435 shares of SANA stock, worth $5.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,145,435

Previous 728,822 57.16%

Holding current value

$5.19 Million

Previous $1.22 Million 155.47%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.34 - $2.97 $558,261 - $1.24 Million	416,613 Added 57.16%	1,145,435 $3.13 Million
Q1 2025 May 13, 2025	BUY	$1.65 - $4.3 $461,948 - $1.2 Million	279,969 Added 62.37%	728,822 $1.22 Million
Q4 2024 Feb 14, 2025	BUY	$1.6 - $4.36 $230,584 - $628,341	144,115 Added 47.29%	448,853 $731,000
Q3 2024 Nov 14, 2024	BUY	$3.76 - $6.86 $241,016 - $439,726	64,100 Added 26.64%	304,738 $1.27 Million
Q2 2024 Aug 13, 2024	SELL	$5.23 - $10.44 $696,055 - $1.39 Million	-133,089 Reduced 35.61%	240,638 $1.31 Million
Q1 2024 May 13, 2024	BUY	$4.2 - $11.27 $278,489 - $747,279	66,307 Added 21.57%	373,727 $3.74 Million
Q4 2023 Feb 09, 2024	BUY	$2.8 - $4.55 $557,424 - $905,814	199,080 Added 183.75%	307,420 $1.25 Million
Q3 2023 Nov 09, 2023	SELL	$3.77 - $6.23 $147,218 - $243,281	-39,050 Reduced 26.49%	108,340 $419,000
Q2 2023 Aug 11, 2023	SELL	$3.22 - $7.53 $50,402 - $117,867	-15,653 Reduced 9.6%	147,390 $878,000
Q1 2023 May 12, 2023	SELL	$3.11 - $4.92 $556,164 - $879,848	-178,831 Reduced 52.31%	163,043 $533,000
Q4 2022 Feb 08, 2023	BUY	$3.19 - $6.46 $899,710 - $1.82 Million	282,041 Added 471.38%	341,874 $1.35 Million
Q3 2022 Nov 10, 2022	SELL	$5.58 - $9.04 $932,786 - $1.51 Million	-167,166 Reduced 73.64%	59,833 $359,000
Q2 2022 Aug 10, 2022	SELL	$4.12 - $9.35 $332,945 - $755,592	-80,812 Reduced 26.25%	226,999 $1.46 Million
Q1 2022 May 16, 2022	BUY	$5.24 - $15.58 $1.03 Million - $3.07 Million	196,844 Added 177.39%	307,811 $2.54 Million
Q4 2021 Feb 14, 2022	BUY	$15.18 - $23.15 $849,503 - $1.3 Million	55,962 Added 101.74%	110,967 $1.72 Million
Q3 2021 Nov 15, 2021	BUY	$16.29 - $25.88 $755,318 - $1.2 Million	46,367 Added 536.78%	55,005 $1.24 Million
Q2 2021 Aug 13, 2021	BUY	$16.65 - $32.14 $68,031 - $131,324	4,086 Added 89.76%	8,638 $170,000
Q1 2021 May 12, 2021	BUY	$23.04 - $43.5 $104,878 - $198,012	4,552 New	4,552 $153,000

Others Institutions Holding SANA

# of Institutions

166

Shares Held

112M

Call Options Held

414K

Put Options Held

295K

View Full List

About Sana Biotechnology, Inc.

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $862M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

More about SANA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account